kinase - Search results :.  Site Info   Whois   Traceroute   RBL Check  

Enter Web Site URL Address:
 

Kinase: 416 results found.

clickenzymesubstrate.biz BIOSYNTH : Enzyme Substrates
Enzyme substrates are offered in large variety from stock. Search your desired product by color, type, and action mode.
Clickenzymesubstrate.biz  ~   Site Info   Whois   Trace Route   RBL Check  
Similar Sites: clickenzymesubstrate.com - clickenzymesubstrate.net
creatineinfocenter.com Creatine InfoCenter
Creatine InfoCenter is your complete guide to creatine and creatine information, including facts about the types of creatine supplements, the effectiveness and side effects of creatine supplementation, and where to buy creatine.
Creatineinfocenter.com  ~   Site Info   Whois   Trace Route   RBL Check  
egfr-info.com EGFR| Epidermal Growth Factor Receptor Testing, News and Resources
Welcome to EGFR-info.com. Here you will find information on EGFR, the
epidermal growth factor receptor, as well as EGFR mutation and testing
information.

Egfr-info.com  ~   Site Info   Whois   Trace Route   RBL Check  
Similar Sites: egfr-mutation.com
moarefi.com Moarefi Consulting
Structure based drug design, biotech, consulting, crystallography,
Moarefi.com  ~   Site Info   Whois   Trace Route   RBL Check  
egfr.net Tarceva.net - Non-Small Cell Lung Cancer (NSCLC) Treatment - Tarceva
Prolong survival with Tarceva®—a targeted lung cancer treatment
Egfr.net  ~   Site Info   Whois   Trace Route   RBL Check  
signalwayantibody.com Signalway Antibody - Products
Signalway Antibody(SAB) develops rabbit polyclonal phospho-specific antibodies,rabbit monoclonal,mouse monoclonal for studying protein phosphorylation in cell signal transduction and cell functions.
Signalwayantibody.com  ~   Site Info   Whois   Trace Route   RBL Check  
smbiochemicals.com SMBiochemicals-QVD-OPH-Z-VAD-FMK- Z-DEVD-FMK-Caspase inhibitor and substrates
Q-VD-OPH, A new generation broad spectrum Caspase Inhibitor QVDOPH is a non- FMK new generation broad spectrum inhibitor that offers improvement in potency, stability and toxicity over the bench mark caspase inhibitor Z-VAD-FMK. Q-VD-OPH doesn’t cross reacts with cathepsins or calpains and FMK (Fluoromethyl Ketones) does. The improvements derive from significant changes that include replacement of the carbobenzoyloxy blocking group (Z) with a Quinoline derivative (Q), modification of the tripeptide sequence from VAD to VD, and replacement of fluoromethyl ketone (FMK) with the non toxic 2,6-difluorophenoxy methyl (OPH) group. The mechanism of action involves the formation of an irreversible thioether bond between the aspartic acid derivative in the inhibitor and the active site cysteine with displacement of 2,6-difluorphenoxy group. Q-VD-OPH is a small hydrophobic compound . Therefore, DMSO is required for solubilization. Stock solutions as high as 200 mg / ml have been prepared in DMSO. To retain solubility in water at concentrations above 1 mg / ml, 80 % DMSO is suggested. Q-VD-OPH is effective in vitro at concentrations of 10uM to 20uM. For tissue culture studies 10mM or 20mM stock solutions are prepared in DMSO and diluted 1:1000 directly into the tissue culture medium. For studies in vivo Q-VD-OPH has been administered in 80% to 100% DMSO to assure solubility at the doses given. A dose of 20mg/Kg has been used most frequently. Q-VD-OPH has been shown to inhibit recombinant Caspases 2, 3, 8 and 9 with IC50 values ranging from 25 to 400 nM. A preliminary acute toxicity screen was done in which mice were injected IP with 200 mg/kg, 500 mg/kg or 1000 mg /kg in 100 % DMSO. Mice were sacrificed and autopsied 24 hours later. No gross pathologies were seen and no evidence of toxicity was observed in histological sections from major organs. Q-VD-OPH, A new generation broad spectrum Caspase Inhibitor Q-VD-OPH is a non- FMK new generation broad spectrum inhibitor that offers improvement in potency, stability and toxicity over the bench mark caspase inhibitor Z-VAD-FMK. Q-VD-OPH doesn’t cross reacts with cathepsins or calpains and FMK (Fluoromethyl Ketones) does. The improvements derive from significant changes that include replacement of the carbobenzoyloxy blocking group (Z) with a Quinoline derivative (Q), modification of the tripeptide sequence from VAD to VD, and replacement of fluoromethyl ketone (FMK) with the non toxic 2,6-difluorophenoxy methyl (OPH) group. The mechanism of action involves the formation of an irreversible thioether bond between the aspartic acid derivative in the inhibitor and the active site cysteine with displacement of 2,6-difluorphenoxy group. Q-VD-OPH is a small hydrophobic compound . Therefore, DMSO is required for solubilization. Stock solutions as high as 200 mg / ml have been prepared in DMSO. To retain solubility in water at concentrations above 1 mg / ml, 80 % DMSO is suggested. Q-VD-OPH is effective in vitro at concentrations of 10uM to 20uM. For tissue culture studies 10mM or 20mM stock solutions are prepared in DMSO and diluted 1:1000 directly into the tissue culture medium. For studies in vivo Q-VD-OPH has been administered in 80% to 100% DMSO to assure solubility at the doses given. A dose of 20mg/Kg has been used most frequently. Q-VD-OPH has been shown to inhibit recombinant Caspases 2, 3, 8 and 9 with IC50 values ranging from 25 to 400 nM.
Smbiochemicals.com  ~   Site Info   Whois   Trace Route   RBL Check  
acccorporation.com American Custom Chemicals Corporation
American Custom Chemicals Corporation (ACC Corp.) provides catalog compounds & custom synthesis for chemicals, biologics, research formulations, equipment & medicinal compounds used for drug discovery & development. Amino acid Antibodies Antigen Apoptosis & Kinase Inhibitor Biomarker Cytokine Enzymes Herbals Nutraceutical Oligos Plant Extract Protein Steroid Hormone Peptide Linker Agrochemical API Boronic acid Carbohydrate Cores Dye Fluorochemical Inorganic Nucleoside Screening Pesticide Vitamin
Acccorporation.com  ~   Site Info   Whois   Trace Route   RBL Check  
Similar Sites: accbiologics.com
biochempartner.com HOME--PI3K;AKT;HDAC;ALK;PARP;mTOR;c-Met;Bcl-2 inhibitors--biochempartner
our product include:PI3K inhibitors;AKT inhibitors;mTOR inhibitors;c-MET inhibitors;HDAC Inhibitors;Bcl-2 Protein Family Inhibitors;Aurora Kinase Inhibitors;ALK Inhibitor;PARP inhibitor;AUR inhibitors;Agonist;Antagonist
Biochempartner.com  ~   Site Info   Whois   Trace Route   RBL Check  
actakine.com Home - Kinacept
Kinacept is a cooperative project in which small drug discovery companies from Germany, Austria and the UK work with European Research Institutes on new therapies for inflammatory diseases.
Actakine.com  ~   Site Info   Whois   Trace Route   RBL Check  
 


Page 8/24« Previous678910Next »
  IP Index    TLD Index    Domain Index    Site Index      Copyright © 2013 dawhois.com